Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.05)
# 530
Out of 5,072 analysts
387
Total ratings
44.22%
Success rate
14.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $37.44 | +33.56% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.26 | +128.14% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $451.23 | +26.32% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.55 | +620.72% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $3.89 | +285.60% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $13.85 | -27.80% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.43 | +105.76% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.46 | +2,069.20% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.74 | +1,012.76% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $39.50 | +153.16% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.51 | +154.45% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +401.61% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.44 | +1,002.94% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $52.70 | +51.80% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.16 | +163.85% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.09 | +633.50% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $35.29 | +98.36% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $25.33 | +215.83% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.69 | +271.75% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.34 | +199.40% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.65 | +334.78% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.42 | +1,613.40% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $70.71 | +20.21% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.18 | +2,327.18% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.95 | +425.10% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $143.86 | +136.34% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $37.44
Upside: +33.56%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $5.26
Upside: +128.14%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $451.23
Upside: +26.32%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.55
Upside: +620.72%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.89
Upside: +285.60%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $13.85
Upside: -27.80%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.43
Upside: +105.76%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.46
Upside: +2,069.20%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.74
Upside: +1,012.76%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $39.50
Upside: +153.16%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $27.51
Upside: +154.45%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +401.61%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $5.44
Upside: +1,002.94%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $52.70
Upside: +51.80%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.16
Upside: +163.85%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.09
Upside: +633.50%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $35.29
Upside: +98.36%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $25.33
Upside: +215.83%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.69
Upside: +271.75%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.34
Upside: +199.40%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.65
Upside: +334.78%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.42
Upside: +1,613.40%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $70.71
Upside: +20.21%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.18
Upside: +2,327.18%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.95
Upside: +425.10%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $143.86
Upside: +136.34%